scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1111593650 |
P356 | DOI | 10.1186/S12951-019-0446-6 |
P932 | PMC publication ID | 6341625 |
P698 | PubMed publication ID | 30670042 |
P2093 | author name string | Hong Wang | |
Zhipeng Li | |||
Fengchao Wang | |||
Deshun Shi | |||
Qingyou Liu | |||
Zhaojun Duan | |||
Kuiqing Cui | |||
Kongwei Huang | |||
Fuhang Liu | |||
P2860 | cites work | Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis. | Q52726208 |
Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses. | Q53815580 | ||
Safety and Efficacy of an Attenuated Vaccine against Severe Rotavirus Gastroenteritis | Q56995254 | ||
Hematoxylin and Eosin Staining of Tissue and Cell Sections | Q58006521 | ||
Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity | Q70998772 | ||
The internal rotavirus protein VP6 primes for an enhanced neutralizing antibody response | Q73992558 | ||
Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal delivery | Q80607738 | ||
Production of two vaccinating recombinant rotavirus proteins in the milk of transgenic rabbits | Q81546580 | ||
Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection | Q81917238 | ||
Rotavirus vaccines WHO position paper: January 2013 - Recommendations | Q86916352 | ||
Characterization of bioactive recombinant human lysozyme expressed in milk of cloned transgenic cattle | Q21004096 | ||
Rotaviruses: from pathogenesis to vaccination | Q24609374 | ||
A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy | Q26820819 | ||
Cattle mammary bioreactor generated by a novel procedure of transgenic cloning for large-scale production of functional human lactoferrin | Q28473868 | ||
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies | Q30430925 | ||
Oral Administration of a Seed-based Bivalent Rotavirus Vaccine Containing VP6 and NSP4 Induces Specific Immune Responses in Mice | Q33740676 | ||
Sequence analysis of the gene (6) encoding the major capsid protein (VP6) of group C rotavirus: higher than expected homology to the corresponding protein from group A virus | Q33945090 | ||
Recombinant protein expression in milk of livestock species | Q34097145 | ||
Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine. | Q34290838 | ||
Human breast milk: A review on its composition and bioactivity | Q34494389 | ||
Nutritional and physiologic significance of human milk proteins | Q34648576 | ||
Production of pharmaceutical proteins by transgenic animals | Q34744705 | ||
Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. | Q34791255 | ||
Expression and characterization of bioactive recombinant human alpha-lactalbumin in the milk of transgenic cloned cows. | Q34889966 | ||
Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression | Q35103038 | ||
More than one reason to rethink the use of peptides in vaccine design | Q36808693 | ||
Ferritins: a family of molecules for iron storage, antioxidation and more. | Q37301997 | ||
Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis | Q38028997 | ||
Modern subunit vaccines: development, components, and research opportunities | Q38073752 | ||
Infant formula and infant nutrition: bioactive proteins of human milk and implications for composition of infant formulas | Q38180950 | ||
Rotavirus VP6 preparations as a non-replicating vaccine candidates. | Q38506308 | ||
Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer | Q38770216 | ||
Vaccine technologies: From whole organisms to rationally designed protein assemblies | Q38806558 | ||
Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. | Q39290987 | ||
Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins | Q39752998 | ||
Structure-based design of ferritin nanoparticle immunogens displaying antigenic loops of Neisseria gonorrhoeae | Q40104608 | ||
Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants | Q40433532 | ||
Neutralizing antiviral B cell responses | Q41464284 | ||
Expression of rotavirus capsid protein VP6 in transgenic potato and its oral immunogenicity in mice | Q44965400 | ||
Large scale production of recombinant human lactoferrin in the milk of transgenic cows | Q45231378 | ||
A plant-based multicomponent vaccine protects mice from enteric diseases | Q45877640 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nanoparticle | Q61231 |
pharmaceutical science | Q7180763 | ||
bioengineering | Q580689 | ||
self-assembly | Q910150 | ||
molecular medicine | Q3523816 | ||
rotavirus VP6 | Q123050125 | ||
P304 | page(s) | 13 | |
P577 | publication date | 2019-01-22 | |
P1433 | published in | Journal of Nanobiotechnology | Q15752156 |
P1476 | title | A milk-based self-assemble rotavirus VP6-ferritin nanoparticle vaccine elicited protection against the viral infection | |
P478 | volume | 17 |
Q97092977 | A ferritin nanoparticle vaccine for foot-and-mouth disease virus elicited partial protection in mice | cites work | P2860 |
Search more.